Unknown primary tumours.
暂无分享,去创建一个
[1] J. Hainsworth,et al. Treatment of patients with cancer of an unknown primary site. , 1993, The New England journal of medicine.
[2] T. Horn,et al. [Electron microscopy of needle biopsies from cancer patients with unknown primary tumors]. , 1993, Ugeskrift for laeger.
[3] A. Maiche. Cancer of Unknown Primary A Retrospective Study Based on 109 Patients , 1993, American journal of clinical oncology.
[4] I. Ellis,et al. Use of tumour marker immunoreactivity to identify primary site of metastatic cancer. , 1993, BMJ.
[5] J. Hainsworth,et al. Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] D. Johnson,et al. Poorly differentiated carcinoma of unknown primary site: clinical usefulness of immunoperoxidase staining. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] E. Dmitrovsky,et al. Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies. , 1991, Journal of the National Cancer Institute.
[8] P. Frost. Unknown primary tumors: an example of accelerated (type 2) tumor progression. , 1991, Basic life sciences.
[9] F. Braud. Metastatic squamous cell carcinoma of an unknown primary localized to the neck , 1990 .
[10] E. Dmitrovsky,et al. Isochromosome 12p in non-seminoma cell lines: karyologic amplification of c-ki-ras2 without point-mutational activation. , 1990, Oncogene.
[11] J. Kay,et al. Identification of primary tumour site by immunolocalization of progastricsin in metastatic adenocarcinoma , 1990, The Journal of pathology.
[12] E. Dmitrovsky,et al. Cytogenetic and molecular analysis of human male germ cell tumors: Chromosome 12 abnormalities and gene amplification , 1990, Genes, chromosomes & cancer.
[13] D. Niedzwiecki,et al. Metastatic Adenocarcinomas of Unknown Primary Site: Prognostic Variables and Treatment Results , 1990, American journal of clinical oncology.
[14] R. Glynne-Jones,et al. Metastatic carcinoma in the cervical lymph nodes from an occult primary: a conservative approach to the role of radiotherapy. , 1990, International journal of radiation oncology, biology, physics.
[15] Kathleen R. Cho,et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.
[16] J. Verweij,et al. Carcinoma of unknown primary: identification of a treatable subset? , 1990, Annals of oncology : official journal of the European Society for Medical Oncology.
[17] E. Dmitrovsky,et al. Isochromosome of Chromosome 12: Clinically Useful Marker for Male Germ Cell Tumors , 1989 .
[18] C. Bell,et al. Unknown primary tumors: establishment of cell lines, identification of chromosomal abnormalities, and implications for a second type of tumor progression. , 1989, Cancer research.
[19] K. Offit,et al. 18q21 rearrangement in diffuse large cell lymphoma: incidence and clinical significance , 1989, British journal of haematology.
[20] P. Rubin,et al. Correlation of prostate‐specific acid phosphatase and prostate‐specific antigen immunocytochemistry with survival in prostate carcinoma , 1989, Cancer.
[21] G. Kovacs,et al. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. , 1989, Cancer research.
[22] H. Bruckner,et al. Leucovorin and 5-fluorouracil as a treatment for disseminated cancer of the pancreas and unknown primary tumors. , 1988, Cancer research.
[23] J. Rothbard,et al. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. , 1988, The Journal of biological chemistry.
[24] J. Hainsworth,et al. Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity. , 1988, Annals of internal medicine.
[25] T. Chevalier,et al. Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. , 1988, Archives of internal medicine.
[26] J. Hainsworth,et al. Curative Combination Chemotherapy for Patients with Advanced Poorly Differentiated Carcinoma of Unknown Primary Site , 1988, American journal of clinical oncology.
[27] C. Bloomfield,et al. Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma. , 1988, Annals of internal medicine.
[28] R. Vanni,et al. Cytogenetic investigation on 30 bladder carcinomas. , 1988, Cancer genetics and cytogenetics.
[29] J. Osinga,et al. Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer , 1987, Nature.
[30] B. Dutrillaux,et al. Characteristic chromosomal imbalances in 18 near-diploid colorectal tumors. , 1987, Cancer genetics and cytogenetics.
[31] M. Salvatore,et al. High serum thyroglobulin levels: Diagnostic indicators in patients with metastases from unknown primary sites , 1987, Cancer.
[32] J. Minna,et al. Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. , 1987, The New England journal of medicine.
[33] Iqbal Unnisa Ali,et al. Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia , 1987 .
[34] B. Vogelstein,et al. Clonal analysis of human colorectal tumors. , 1987, Science.
[35] I. Ellis,et al. A combined serological and immunohistological investigation of CA 125 antigen and malignant ovarian epithelial tumours , 1987 .
[36] A. Langlands,et al. ACUPS (adenocarcinoma of unknown primary site): a clinical and cost benefit analysis. , 1987, International journal of radiation oncology, biology, physics.
[37] J. Hainsworth,et al. Poorly differentiated carcinoma of unknown primary site: correlation of light microscopic findings with response to cisplatin-based combination chemotherapy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] K. Offit,et al. Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes. , 1987, Blood.
[39] D. Sheer,et al. Cytogenetic analysis of four human ovarian carcinoma cell lines. , 1987, Cancer genetics and cytogenetics.
[40] N. B. Atkin,et al. Abnormal chromosomes including small metacentrics in 14 ovarian cancers. , 1987, Cancer genetics and cytogenetics.
[41] P. Carroll,et al. Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma. , 1987, Cancer genetics and cytogenetics.
[42] D. Hedley,et al. Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets. , 1987, The Quarterly journal of medicine.
[43] M. Tattersall,et al. Cytogenetic findings in cell lines derived from four ovarian carcinomas. , 1987, Cancer genetics and cytogenetics.
[44] M. Oken,et al. Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. , 1987, The New England journal of medicine.
[45] S. Jhanwar,et al. Cytogenetic and histologic correlations in malignant lymphoma. , 1987, Blood.
[46] M. Burgess,et al. Prognostic factors in metastatic carcinoma of unknown primary. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] M. Raben,et al. Metastatic carcinoma of the neck from an unknown primary. , 1986, International journal of radiation oncology, biology, physics.
[48] E. Bartucci,et al. The search for the primary tumor in patients with skeletal metastases of unknown origin , 1986, Cancer.
[49] M. Kemeny,et al. Occult primary adenocarcinoma with axillary metastases. , 1986, American journal of surgery.
[50] A. Gown,et al. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. , 1986, The American journal of pathology.
[51] D. O'Connor,et al. Secretion of chromogranin A by peptide-producing endocrine neoplasms. , 1986, The New England journal of medicine.
[52] J. Hainsworth,et al. Advanced poorly differentiated carcinoma of unknown primary site: recognition of a treatable syndrome. , 1986, Annals of internal medicine.
[53] R. Goldberg,et al. 5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] K. Dasmahapatra,et al. Management of squamous cell carcinoma of unknown origin in cervical lymph nodes. , 1986, The American surgeon.
[55] J. Bennett,et al. Nonrandom chromosome structural aberrations and oncogene loci in human malignant melanoma. , 1986, Cancer genetics and cytogenetics.
[56] F. Hecht,et al. Chromosome change in transitional cell carcinoma of ureter. , 1986, Cancer genetics and cytogenetics.
[57] P. Nowell,et al. Karyotypic evolution in human malignant melanoma. , 1986, Cancer genetics and cytogenetics.
[58] E. Cadman,et al. An analysis of 1539 patients with cancer of unknown primary site , 1986, Cancer.
[59] B. Levin,et al. Chromosomes and large bowel tumors. , 1986, Cancer Genetics and Cytogenetics.
[60] E. Casper,et al. Adenocarcinoma of unknown primary origin: treatment with vindesine and doxorubicin. , 1985, Cancer treatment reports.
[61] J. Connors,et al. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. , 1985, Annals of internal medicine.
[62] W. E. Jordan,et al. Adenocarcinoma of unknown primary site. The brooke army medical center experience , 1985, Cancer.
[63] J. Bergh,et al. Karyotypic characterization of established cell lines and short-term cultures of human lung cancers. , 1985, Cancer genetics and cytogenetics.
[64] McCaughey Wt. Papillary peritoneal neoplasms in females. , 1985 .
[65] H. Ga,et al. Electron microscopy in determining origin of metastatic adenocarcinomas. , 1984 .
[66] R. W. Baldwin,et al. A monoclonal antibody, NCRC‐11, raised to human breast carcinoma. 1. Production and immunohistological characterization , 1984, Histopathology.
[67] R. Kempson,et al. Primary mucinous adenocarcinoma of the endometrium: A clinicopathologic and histochemical study* , 1983, The American journal of surgical pathology.
[68] R. Spiro,et al. Cervical node metastasis of occult origin. , 1983, American journal of surgery.
[69] W. Hanafee,et al. Elusive head and neck carcinomas beneath intact mucosa , 1983, The Laryngoscope.
[70] J. Earle,et al. Application of epstein‐barr virus (EBV) serology to the diagnosis of north american nasopharyngeal carcinoma , 1983 .
[71] S. Balcerzak,et al. Management of patients with metastatic adenocarcinoma of unknown origin: a Southwest Oncology Group study. , 1983, Cancer treatment reports.
[72] W. Cai,et al. Lymph node metastases in the neck from an unknown primary. Report on 113 patients. , 1983, Acta radiologica. Oncology.
[73] N. B. Atkin,et al. SPECIFIC CHROMOSOME CHANGE, i(12p), IN TESTICULAR TUMOURS? , 1982, The Lancet.
[74] Nystrom Js,et al. Metastatic cancer of unknown origin: nonsquamous cell type. , 1982 .
[75] N. Ordóñez,et al. The role of the pathologist in the evaluation of poorly differentiated tumors. , 1982, Seminars in Oncology.
[76] T. Nakajima,et al. An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues , 1982, The American journal of surgical pathology.
[77] P. Sheedy,et al. Computed tomography in search of cancer of unknown origin. , 1982, JAMA.
[78] E. Levine,et al. Computed tomography in the evaluation of metastatic adenocarcinoma from an unknown primary site. A retrospective study. , 1982, Radiology.
[79] T. Parmley,et al. Primary, Papillary Peritoneal Neoplasia , 1981, Obstetrics and gynecology.
[80] Takuma Nemoto,et al. Axillary lymph node metastasis from an occult breast cancer , 1981, Cancer.
[81] W. Taylor,et al. Immunologic Detection of Occult Primary Cancer of the Head and Neck , 1981, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[82] F. Greco,et al. The unrecognized extragonadal germ cell cancer syndrome. , 1981, Annals of internal medicine.
[83] M. Tattersall,et al. Metastatic adenocarcinomas of unknown primary site: a randomized study of two combination-chemotherapy regimens. , 1980, The New England journal of medicine.
[84] M. Tattersall,et al. UNDIFFERENTIATED CARCINOMA IN YOUNG MEN: THE ATYPICAL TERATOMA SYNDROME , 1979, The Lancet.
[85] M. Tattersall,et al. Unknown primary adenocarcinoma: incidence of overinvestigation and natural history. , 1979, British medical journal.
[86] M. Viola,et al. Identifying the primary site in metastatic cancer of unknown origin. Inadequacy of roentgenographic procedures. , 1979, JAMA.
[87] W. Caldwell,et al. Metastasis to neck from unknown primary tumor. , 1979, Acta radiologica: oncology, radiation, physics, biology.
[88] H. Latourette,et al. Cervical lymph node metastases from an unknown primary. , 1979, International journal of radiation oncology, biology, physics.
[89] Devine Kd. Cancer in the neck without obvious source. , 1978 .
[90] H. Zaren,et al. Inguinal node metastases , 1978, Cancer.
[91] E. Elias,et al. Metastatic Carcinomas from Occult Primary Tumors: A Study of 254 Patients , 1977, Annals of surgery.
[92] R. G. Chambers,et al. Metastases to lymph nodes of the head and neck from an unknown primary site. , 1977, American journal of surgery.
[93] R. M. Wolf,et al. Metastatic and histologic presentations in unknown primary cancer. , 1977, Seminars in oncology.
[94] J. Urban,et al. Breast Cancer Presenting as an Axillary Mass , 1976, Annals of surgery.
[95] T. Waldmann,et al. Serum α-Fetoprotein in Patients with Neoplasms of the Gastrointestinal Tract , 1975 .
[96] R. Hahn,et al. Treatment of the patient with adenocarcinoma of unknown origin , 1972, Cancer.
[97] H. Gallager,et al. Breast carcinoma presenting as an axillary mass. , 1971, American journal of surgery.
[98] F. Holmes,et al. Metastatic cancer of unknown primary site. , 1970, Cancer.
[99] Spratt Js,et al. Metastatic carcinoma in cervical lymph nodes from occult primary sites. A review. , 1967 .
[100] Dockerty Mb,et al. Occult carcinoma of the breast. , 1954 .